XCUR

Exicure Inc. Common Stock (XCUR)

Stock · NASDAQ · Health Care

$1.12as of 10/16/2026

Price chart

Open in TradingView

Active signals

High Beta100.0%
200 SMA Touch0.0%
Resistance level
$1.28
Industry
Biotechnology: Pharmaceutical Preparations

XCUR Signal Track Record

How signals performed across all stocks →

What XCUR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike27-15.6%33%
Bollinger Band Breakdown23-8.9%30%
Bollinger Band Breakout15-22.9%13%
200-Day Moving Average TouchActive now5-11.5%40%
Any 20-session window (baseline)-10.8%33%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About XCUR

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
1

Fundamentals

1-day range
$1.08$1.21
Market cap
$8.60M
P/E (trailing)
—
P/E (forward)
-1.45
EPS (trailing)
$-1.30
Dividend yield
—
Beta
3.86
Avg. volume
49.0K
52-week range
$0.936$9.48

How Exicure Inc. Common Stock Makes Money

Where the revenue actually goes — FY2024 annual results

market-wall.comTotalRevenue$500.0KSG&A$5.45M (1090%)Tax$8.0K (2%)XCUR

Source: 10-K filed Mar 18, 2025 · via SEC EDGAR / Finnhub

Operating Income-$12.23M(-2446%)

Exicure Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • XCUR
    Exicure Inc. Common Stock
    $1.12
    ▲ 0.00%
    Market cap $8.60MP/E —
    $0.936$9.48
  • LEXX
    Lexaria Bioscience Corp. Common Stock
    $2.86
    ▼ 4.35%
    Market cap $8.82MP/E —
    $2.43$21.6
  • KAPA
    Kairos Pharma Ltd. Common Stock
    $0.601
    ▼ 10.43%
    Market cap $8.35MP/E —
    $0.7108$9.17
  • IMRN
    Immuron Limited American Depositary Shares
    $0.982
    ▼ 4.66%
    Market cap $8.88MP/E —
    $0.026$0.098
  • SNGX
    Soligenix Inc. Common Stock
    $0.35
    ▼ 2.78%
    Market cap $8.24MP/E —
    $0.28$1.76
  • TRAW
    Traws Pharma Inc. Common Stock
    $0.37
    ▼ 7.50%
    Market cap $8.21MP/E —
    $0.391$3.23
  • ASBP
    Aspire Biopharma Holdings Inc. Common Stock
    $8.78
    ▲ 1.62%
    Market cap $9.14MP/E —
    $3.31$562.8

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
623.3K
Disposed
0
  • Exicure HiTron Inc. · July 8, 2026 · J
    117.4K @ $4.5
  • Exicure HiTron Inc. · June 26, 2026 · J
    253.2K @ $4.5
  • Exicure HiTron Inc. · June 24, 2026 · J
    123.5K @ $4.5
  • Exicure HiTron Inc. · June 23, 2026 · J
    129.2K @ $4.5

Institutional Ownership

March 31, 2026

Total shares held
148.1K
Total value held
$630.8K
Institutional holders
16
Top holders this quarter
  • Unknown56.3K
  • Unknown36.9K
  • Unknown33.0K
  • Unknown10.7K
  • Unknown9.4K
  • Unknown866
  • Unknown489
  • Unknown158
  • Unknown120
  • Unknown120

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.